JAC-Antimicrobial Resistance

  29 April 2019

JAC-Antimicrobial Resistance (JAC-AMR) is a new fully open access journal from the British Society for Antimicrobial Chemotherapy. The journal publishes academic content, as well as peer review commentaries on stewardship resources.

The education component of JAC-AMR is an innovative online repository for educational resources intended to support learning and increase knowledge about antimicrobial stewardship practice, antimicrobial resistance, behaviour change and more, for a worldwide audience. JAC-AMR will provide commentary and peer review on the educational resource, written by an Editor of the Journal. This will take the form of a structured review of the content of the resource. These reviews will be candid and serve to guide users of the resources as to the type of resource, intended audience, expected time to complete the resource and so on, as well as an assessment of any gaps or weaknesses in the resource.

The research component will publish clinically oriented opinions, reviews and original articles that advance the science and knowledge of antimicrobial resistance, stewardship and use relating to antibacterial, antifungal, antiviral and antiprotozoal agents. The Journal publishes primarily in human medicine, but articles in veterinary medicine will be considered, provided they fall within the scope of a regional or global ‘one health’ approach to antimicrobials.

Further reading: Oxford Academic
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!